Search hospitals > New York > Buffalo
Dent Neurologic Institute
Claim this profileBuffalo, New York 14226
Global Leader in Migraine
Global Leader in Alzheimer's Disease
Conducts research for Headache
Conducts research for Multiple Sclerosis
Conducts research for Epilepsy
131 reported clinical trials
10 medical researchers
Summary
Dent Neurologic Institute is a medical facility located in Buffalo, New York. This center is recognized for care of Migraine, Alzheimer's Disease, Headache, Multiple Sclerosis, Epilepsy and other specialties. Dent Neurologic Institute is involved with conducting 131 clinical trials across 74 conditions. There are 10 research doctors associated with this hospital, such as Laszlo Mechtler, Horacio Capote, MD, Jennifer McVige, MD, and Bela Ajtai.Area of expertise
1Migraine
Global Leader2Alzheimer's Disease
Global LeaderApoE positive
ApoE negative
Top PIs
Laszlo MechtlerDent Neurologic Institute1 year of reported clinical research
Studies Obesity
Studies Migraine
5 reported clinical trials
7 drugs studied
Horacio Capote, MDDent Neurologic Institute4 years of reported clinical research
Studies Alzheimer's Disease
Studies Cognitive Impairment
5 reported clinical trials
11 drugs studied
Jennifer McVige, MDDent Neurologic Institute3 years of reported clinical research
Studies Migraine
Studies Headache Disorders
3 reported clinical trials
4 drugs studied
Bela AjtaiDent Neurologic Institute2 years of reported clinical research
Studies Alzheimer's Disease
Studies Mild Cognitive Impairment
3 reported clinical trials
5 drugs studied
Clinical Trials running at Dent Neurologic Institute
Migraine
Multiple Sclerosis
Alzheimer's Disease
Obesity
Epilepsy
Dementia
Parkinson's Disease
Psychomotor Agitation
Mild Cognitive Impairment
Alzheimer's Dementia
Atogepant + Botox
for Chronic Migraine
This trial is testing a new daily pill called atogepant, used along with regular BOTOX treatments, to help prevent migraines. It targets adults who suffer from frequent and severe headaches. The pill works by blocking certain brain signals that trigger migraines. The study will monitor safety, side effects, and effectiveness over several months. Atogepant is a newly approved medication for the prevention of migraine.
Recruiting2 awards Phase 33 criteria
Rimegepant
for Pediatric Migraine
This trial aims to test the safety of rimegepant, a medication for treating migraines. The study focuses on children and adolescents aged 6 to 17 years who experience moderate to severe migraines. Rimegepant works by blocking a protein that triggers migraine pain, helping to alleviate symptoms.
Recruiting2 awards Phase 38 criteria
Galcanezumab
for Pediatric Migraine
The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Recruiting1 award Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Dent Neurologic Institute?
Dent Neurologic Institute is a medical facility located in Buffalo, New York. This center is recognized for care of Migraine, Alzheimer's Disease, Headache, Multiple Sclerosis, Epilepsy and other specialties. Dent Neurologic Institute is involved with conducting 131 clinical trials across 74 conditions. There are 10 research doctors associated with this hospital, such as Laszlo Mechtler, Horacio Capote, MD, Jennifer McVige, MD, and Bela Ajtai.